Login / Signup

Stakeholder perspectives on scaling up medical device reprocessing: A qualitative study.

Rachel HenneinEmily GoddardJodi D Sherman
Published in: PloS one (2022)
Based on our findings, we have outlined a number of recommendations that target these barriers and facilitators so that the environmental and financial benefits of MDR can be realized at this health system and nationally. For example, implementing federal policies that prevent original equipment manufacturers from using tactics of forced obsolescence can facilitate the scale-up of MDR nationally. Additionally, providing life cycle assessments that compare the environmental effects of single-use disposable, reprocessable disposable, and reusable devices could facilitate health systems' purchasing decisions. Creating and disseminating audit and feedback reports to hospital staff might also facilitate their continued engagement in the program. Lastly, hiring a full-time program manager that leads MDR programs within health systems could improve program sustainability.
Keyphrases
  • life cycle
  • quality improvement
  • multidrug resistant
  • public health
  • social media
  • adverse drug
  • risk assessment
  • climate change
  • health insurance
  • long term care